D. E. Shaw & Co., Inc. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$5,658,511
-55.2%
549,370
-28.3%
0.01%
-53.8%
Q2 2023$12,620,977
+342.6%
765,836
+146.0%
0.01%
+333.3%
Q1 2023$2,851,416
+15.9%
311,290
-9.4%
0.00%0.0%
Q4 2022$2,461,286
+39.5%
343,755
-2.4%
0.00%
+50.0%
Q3 2022$1,764,000
+5245.5%
352,114
+2521.5%
0.00%
Q2 2022$33,000
-89.8%
13,432
-59.3%
0.00%
Q3 2021$324,000
+252.2%
33,041
+142.3%
0.00%
Q2 2021$92,000
-10.7%
13,636
-33.0%
0.00%
Q3 2020$103,000
-86.8%
20,342
-78.9%
0.00%
-100.0%
Q2 2020$779,000
+628.0%
96,414
+582.9%
0.00%
Q4 2019$107,000
+114.0%
14,118
-19.0%
0.00%
Q2 2019$50,000
+2.0%
17,425
-48.6%
0.00%
Q1 2019$49,000
-58.5%
33,895
-26.1%
0.00%
Q4 2018$118,000
-60.3%
45,844
-32.1%
0.00%
Q3 2018$297,000
-72.1%
67,540
-61.1%
0.00%
-100.0%
Q2 2018$1,065,000
+53.0%
173,661
+81.9%
0.00%0.0%
Q1 2018$696,000
-67.0%
95,462
-62.9%
0.00%
-66.7%
Q4 2017$2,107,000
-21.1%
256,979
+1.1%
0.00%
-25.0%
Q3 2017$2,669,000
-10.1%
254,194
-5.6%
0.00%
-20.0%
Q2 2017$2,969,000
+22.7%
269,141
+7.7%
0.01%
+25.0%
Q1 2017$2,419,000249,8630.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders